ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion

Georg Jocher(German Center for Neurodegenerative Diseases), Stefan F. Lichtenthaler(German Center for Neurodegenerative Diseases)
EMBO Reports
May 8, 2022
Cited by 126


Related Papers